Dxc Technology SEC Filings

DXC Technology insider Christopher A. Voci filed a Form 144 notice covering a proposed sale of 2,500 shares of DXC common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $37,880.04. The table shows 174,133,947 DXC common shares outstanding. The shares to be sold were acquired via restricted stock vesting from the issuer as compensation, including 185 shares vesting on May 31, 2023 and 2,315 shares vesting on May 21, 2025. The filing also reports that Voci sold 2,500 DXC common shares on September 11, 2025 for gross proceeds of $36,287.53 over the prior three months.

DXC Technology Company is refinancing part of its debt. The company has called for full redemption of its 1.750% Senior Notes due January 2026, covering €650 million of outstanding notes, with a redemption date of December 24, 2025 at 100% of principal plus accrued interest. It also plans a partial redemption of $300 million of its 1.800% Senior Notes due September 2026 on December 19, 2025, at 100% of principal plus a make-whole premium and accrued interest.

To support these actions, wholly owned subsidiary DXC Capital Funding DAC completed an offering of €650.0 million 4.250% Senior Notes due 2030, guaranteed by DXC and a Luxembourg affiliate. These unsecured senior notes pay 4.250% interest annually and mature on December 9, 2030. DXC expects net proceeds of about €632.4 million, which it intends to use to repay existing indebtedness, including the 2026 euro notes, and for working capital and general corporate purposes.

DXC Technology Company disclosed that its wholly owned subsidiary, DXC Capital Funding DAC, has priced an offering of €650,000,000 aggregate principal amount of 4.250% Senior Notes due 2030. These notes are being sold to qualified institutional buyers under Rule 144A in the United States and to investors outside the U.S. under Regulation S. The company also issued a press release announcing the pricing, which is included as an exhibit to the report.

DXC Technology Company filed its quarterly report for the period ended September 30, 2025. Revenue was $3,161 million versus $3,241 million a year ago. Net income attributable to common stockholders was $36 million, with diluted EPS of $0.20 compared with $0.23.

Total costs and expenses fell to $3,030 million from $3,148 million, lifting income before taxes to $131 million from $93 million. The effective tax rate rose to 69.5%, which limited net income growth. Cash from operating activities strengthened to $595 million from $433 million, while cash and cash equivalents were $1,888 million.

DXC repurchased 8,593,166 shares for $125 million at an average price of $14.55. Total debt was $3,982 million, with $1,612 million classified as current (reflecting upcoming note maturities). The company sold $394 million of receivables under its $400 million facility, which were derecognized. Remaining performance obligations were about $16.3 billion.

By segment in the quarter, CES revenue was $1,255 million, GIS $1,586 million, and Insurance $320 million. Shares outstanding were 174,133,947 as of October 20, 2025.

DXC Technology Company furnished an 8-K announcing it issued a press release with financial results for the second quarter of fiscal 2026, covering the period ended September 30, 2025. The company will host a conference call at 5:00 PM ET on October 30, 2025 to discuss the results.

The information in this report is furnished and not deemed filed under the Exchange Act. Included exhibits are the earnings press release (Exhibit 99.1) and the cover page interactive data file (Exhibit 104).

Christopher Anthony Voci, SVP, Controller and PAO of DXC Technology Co (DXC), reported sales of DXC common stock on 09/11/2025. The filing shows two dispositions: 2,499 shares sold at $14.515 and 1 share sold at $14.52. After these transactions the filing reports beneficial ownership of 91,106 and 91,105 shares (the filing notes the totals include unvested Restricted Stock Units). The Form 4 was signed by Matt Fawcett, Attorney-in-Fact, on 09/15/2025.

DXC Technology (Form 144): This notice reports a proposed sale of 2,500 common shares through Fidelity Brokerage Services with an approximate aggregate market value of $36,287.53 and an approximate sale date of 09/11/2025 on the NYSE. The shares were acquired on 05/23/2024 via restricted stock vesting as compensation. The filing also discloses a prior sale of 2,500 shares on 06/11/2025 generating gross proceeds of $39,836.03. The filing omits the issuer name and filer CIK/CCC details in the provided text.

Venkataraman Ramanathan, identified as an officer (EVP, CES) and director of DXC Technology Co (DXC), received an award of 86,780 restricted stock units (RSUs) reported as an acquisition on 08/15/2025. Each RSU converts to one share of common stock upon vesting, and the award will vest in three equal annual installments on the first, second and third anniversaries of the grant date. The form reports the amount includes unvested RSUs and shows 86,780 shares beneficially owned following the transaction. The transaction is recorded with a price of $0 and the Form 4 was signed by an attorney-in-fact, Matt Fawcett, on 08/19/2025.

Anthony Gonzalez, a director of DXC Technology Co (DXC), reported multiple sales of the issuer's common stock on 08/13/2025. The Form 4 shows four separate disposition transactions totaling 12,300 shares sold at prices ranging from $13.78 to $13.79. The filing notes that the reported beneficial ownership amounts include unvested restricted stock units. After the reported sales, Mr. Gonzalez's beneficial ownership in DXC is shown as 34,300 shares.